Activation of cAMP–protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
IFN-alpha has been found to inhibit glucocorticoid receptor (GR) function by activating janus kinase-signal transducer and activator of transcription (JAK-STAT) inflammatory signaling pathways. In contrast, through stimulation of protein kinase A (PKA), cAMP has been shown to enhance GR function and can inhibit inflammatory signaling. We therefore examined whether increased cAMP-PKA pathway activation could reverse IFN-alpha-induced inhibition of GR function and whether decreased cAMP-PKA activity might exacerbate IFN-alpha effects on the GR. Activation of cAMP by forskolin (10uM) reversed the inhibitory effects of mIFN-alpha (1000U/ml) on dexamethasone (DEX)-induced MMTV-luciferase activity in hippocampal HT22 cells. Forskolin treatment also blocked both IFN-alpha-induced activation of phosphorylated STAT5 (pSTAT5) and inhibitory protein-protein interactions between pSTAT5 and GR in the nucleus of HT22 cells treated with IFN-alpha and DEX. These effects of forskolin were reversed by co-administration of the PKA inhibitor, H89. Conversely, the combination of IFN-alpha and treatment with either H89 or siRNA directed against the alpha and beta catalytic subunit isoforms of PKA led to an additive inhibitory effect on DEX-induced GR activity in HT22 cells. Taken together, these findings suggest that inhibition of GR signaling by mIFN-alpha and STAT5 can be reversed by activation of cAMP-PKA pathways, whereas decreased PKA activity increases the inhibitory effect of IFN-alpha on GR function. Given decreased PKA activity found in patients with major depression, these data suggest that depressed patients may be vulnerable to cytokine effects on GR, and cAMP-PKA agonists may serve to reverse glucocorticoid resistance in patients with depression and increased inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 4×
“Studies by our group and others have found that antidepressants also enhance GR function (Pariante and Miller, 2001; Pariante et al., 1997).”
BackgroundInfluentialSelf-citationIL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 1×
“A number of studies have shown that inflammatory cytokines can inhibit neurogenesis both in vivo and in vitro (Koo and Duman, 2008; Koo et al.; Yirmiya and Goshen, 2011).”
BackgroundPace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Self-citationNuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., & Duman, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910658107 · Cited by 607
Neuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Self-citationAntidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
Anacker, C., Zunszain, P. A., Cattaneo, A., Carvalho, L. A., Garabedian, M. J., Thuret, S., Price, J., & Pariante, C. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.26 · Cited by 435 · cited 2×
“A recent study by Anacker and colleagues demonstrated that neuronal cultures treated with sertraline for 3 days displayed increased neurogenesis that was blocked by the selective GR antagonist, RU38486 (Anacker et al., 2011) .”
BackgroundMechanisms of glucocorticoid receptor signaling during inflammation
Smoak, K. A., & Cidlowski, J. A. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.06.010 · Cited by 420
The Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 1×
“This finding agrees with reports by others indicating that antidepressants enhance GR function, at least in part by modulating cAMP-PKA function (Blendy, 2006; Eickelberg et al., 1999; Funato et al., 2006; Pariante et al., 2003; Rangarajan et al., 1992).”
ResultCrosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase
Saxena, M., Williams, S., Taskén, K., & Mustelin, T. (1999) · Nature Cell Biology · doi:10.1038/13024 · Cited by 203 · cited 6×
“Interestingly, PKA has also been shown to inhibit a number of inflammatory signaling pathways including nuclear factor-κB (NF-κB)(Gao et al., 2010; Takahashi et al., 2002; Zhang et al., 2010) and mitogen activated protein kinase (MAPK)(e.g. Park et al., 2010; Saxena et al., 1999).”
BackgroundInfluentialRaison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183
Self-citationMelck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzmán, M., & Di Marzo, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01639-7 · Cited by 168 · cited 2×
“, 2004), and activation of PKA by forskolin has been shown to inhibit MAPK-induced raf-1 translocation (Melck et al., 1999).”
BackgroundSteroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
Pariante, C. M., Pearce, B. D., Pisell, T. L., Owens, M. J., & Miller, A. H. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.571 · Cited by 156
Self-citationThe mechanism of cAMP-induced Glucocorticoid Receptor Expression
Dong, Y., Aronsson, M., Gustafsson, J. A., & Okret, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80050-3 · Cited by 135
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128 · cited 4×
“, 1999) and their signaling pathways (Biola et al., 2001; Goleva et al., 2002; Hu et al., 2009; Wang et al., 2005; Wang et al., 2004), including IFN-alpha and the JAKSTAT pathway, impair activity of GR.”
BackgroundInfluentialSelf-citationDoucas, V., Shi, Y., Miyamoto, S., West, A., Verma, I., & Evans, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413297 · Cited by 125 · cited 4×
“Given prior studies demonstrating synergies between GR and PKA (Dong et al., 1989; Doucas et al., 2000; Eickelberg et al., 1999; Gruol et al., 1986; Haske et al., 1994; Medh et al., 1998; Miller et al., 2002; Penuelas et al., 1998), we hypothesized that treatment of mouse HT22 cells with the cAMP agonist forskolin wou…”
BackgroundMethodInfluentialA Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance
Goleva, E., Kisich, K. O., & Leung, D. Y. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5934 · Cited by 113 · cited 2×
“, 1999) and their signaling pathways (Biola et al., 2001; Goleva et al., 2002; Hu et al., 2009; Wang et al., 2005; Wang et al., 2004), including IFN-alpha and the JAKSTAT pathway, impair activity of GR.”
BackgroundcAMP-dependent protein kinase activity in major depression
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1037 · Cited by 105 · cited 5×
“…depression as a number of different monoamine neurotransmitters act through G protein-coupled receptors, and evidence of decreased PKA activity has been reported in skin fibroblasts (Shelton et al., 1996; Shelton et al., 1999) and the prefrontal cortex of depressed patients (Shelton et al., 2009).”
BackgroundInfluentialCyclic AMP-dependent protein kinase promotes glucocorticoid receptor function.
Gruol, D. J., Campbell, N. F., & Bourgeois, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89191-3 · Cited by 94
Tamir, A., Granot, Y., & Isakov, N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1514 · Cited by 79 · cited 1×
“In addition, forskolin has been found to down-regulate extracellular signaling-related kinase (ERK) and JNK, both resulting in reduced T cell activation (Tamir et al., 1996).”
BackgroundPariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300195 · Cited by 70 · cited 1×
“This finding agrees with reports by others indicating that antidepressants enhance GR function, at least in part by modulating cAMP-PKA function (Blendy, 2006; Eickelberg et al., 1999; Funato et al., 2006; Pariante et al., 2003; Rangarajan et al., 1992).”
ResultBiola, A. (2001) · Molecular Endocrinology · doi:10.1210/me.15.7.1062 · Cited by 67 · cited 7×
“A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance.”
BackgroundMethodInfluential(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.211 · Cited by 58
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
Miller, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00381-0 · Cited by 57
Self-citationPariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., & Miller, A. H. (1999) · Endocrinology · doi:10.1210/en.140.9.4359 · Cited by 40
Self-citationFunato, H., Kobayashi, A., & Watanabe, Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.029 · Cited by 28
cAMP activates transcription of the human glucocorticoid receptor gene promoter
Peñuelas, I., Encı́o, I. J., López-Moratalla, N., & Santiago, E. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00097-1 · Cited by 27 · cited 6×
“Given prior studies demonstrating synergies between GR and PKA (Dong et al., 1989; Doucas et al., 2000; Eickelberg et al., 1999; Gruol et al., 1986; Haske et al., 1994; Medh et al., 1998; Miller et al., 2002; Penuelas et al., 1998), we hypothesized that treatment of mouse HT22 cells with the cAMP agonist forskolin wou…”
BackgroundInfluentialHaske, T., Nakao, M., & Moudgil, V. K. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926925 · Cited by 24 · cited 6×
“Given prior studies demonstrating synergies between GR and PKA (Dong et al., 1989; Doucas et al., 2000; Eickelberg et al., 1999; Gruol et al., 1986; Haske et al., 1994; Medh et al., 1998; Miller et al., 2002; Penuelas et al., 1998), we hypothesized that treatment of mouse HT22 cells with the cAMP agonist forskolin wou…”
BackgroundMethodInfluentialTakahashi, E., Onda, K., Hirano, T., Oka, K., Maruoka, N., Tsuyuguchi, M., Matsumura, Y., Niitsuma, T., & Hayashi, T. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00083-8 · Cited by 20 · cited 4×
“Interestingly, PKA has also been shown to inhibit a number of inflammatory signaling pathways including nuclear factor-κB (NF-κB)(Gao et al., 2010; Takahashi et al., 2002; Zhang et al., 2010) and mitogen activated protein kinase (MAPK)(e.g. Park et al., 2010; Saxena et al., 1999).”
BackgroundInfluential
Cited by
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
The Emerging Field of Human Social Genomics
Slavich, G. M., & Cole, S. W. (2013) · Clinical Psychological Science · doi:10.1177/2167702613478594 · Cited by 523
Molecular links between endocrine, nervous and immune system during chronic stress
Zefferino, R., Di Gioia, S., & Conese, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1960 · Cited by 204
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343980 · Cited by 57
Metadata
- Authors
- Pace, T. W. W., Hu, F., & Miller, A. H.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 25
- Issue
- 8
- Pages
- 1716-1724
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2168514591
- Cited by
- 28
- References
- 29
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.